本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

70.76
+3.845.73%
成交量:30.03万
成交额:2,103.10万
市值:30.03亿
市盈率:-44.50
高:71.10
开:67.58
低:66.38
收:66.92
52周最高:85.25
52周最低:38.51
股本:4,244.91万
流通股本:3,035.16万
量比:1.45
换手率:0.99%
股息:- -
股息率:- -
每股收益(TTM):-1.5900
每股收益(LYR):-1.5900
净资产收益率:-23.39%
总资产收益率:-9.45%
市净率:8.75
市盈率(LYR):-44.50

数据加载中...

2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities